BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34927983)

  • 1. DNA-Directed Assembly of a Cell-Responsive Biohybrid Interface for Cargo Release.
    Sun P; Scharnweber T; Wadhwani P; Rabe KS; Niemeyer CM
    Small Methods; 2021 Jul; 5(7):e2001049. PubMed ID: 34927983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopebble Containers: DNA-Directed Surface Assembly of Mesoporous Silica Nanoparticles for Cell Studies.
    Sun P; Leidner A; Weigel S; Weidler PG; Heissler S; Scharnweber T; Niemeyer CM
    Small; 2019 May; 15(20):e1900083. PubMed ID: 30985076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-cargo selectively controlled release based on a pH-responsive mesoporous silica system.
    Gui W; Wang W; Jiao X; Chen L; Wen Y; Zhang X
    Chemphyschem; 2015 Feb; 16(3):607-13. PubMed ID: 25492672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
    Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better.
    Nadrah P; Porta F; Planinšek O; Kros A; Gaberšček M
    Phys Chem Chem Phys; 2013 Jul; 15(26):10740-8. PubMed ID: 23689395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
    Saroj S; Rajput SJ
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
    Liu Y; Ding X; Li J; Luo Z; Hu Y; Liu J; Dai L; Zhou J; Hou C; Cai K
    Nanotechnology; 2015 Apr; 26(14):145102. PubMed ID: 25789511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.
    Paris JL; Cabañas MV; Manzano M; Vallet-Regí M
    ACS Nano; 2015 Nov; 9(11):11023-33. PubMed ID: 26456489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
    Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
    Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system.
    Knežević NŽ; Trewyn BG; Lin VS
    Chem Commun (Camb); 2011 Mar; 47(10):2817-9. PubMed ID: 21240408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin-gated mesoporous silica nanoparticles as drug carriers for red light-induced drug release.
    Chai S; Guo Y; Zhang Z; Chai Z; Ma Y; Qi L
    Nanotechnology; 2017 Apr; 28(14):145101. PubMed ID: 28281469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery.
    Chen W; Glackin CA; Horwitz MA; Zink JI
    Acc Chem Res; 2019 Jun; 52(6):1531-1542. PubMed ID: 31082188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.